JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know. Evangelatos G, Fragoulis GE. Clin Rheumatol 2023;42:959-962.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Evangelatos G, Fragoulis GE. JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know. Clin Rheumatol 2023;42:959-962.
PMID: 36512165